Dry adsorbed emulsion:: 2.: Dissolution behaviour of an intricate formulation

被引:15
作者
Chambin, O [1 ]
Bérard, V [1 ]
Rochat-Gonthier, MH [1 ]
Pourcelot, Y [1 ]
机构
[1] Univ Bourgogne, UFR Pharm, Grp Technol Poudres Usage Pharmaceut, F-21079 Dijon, France
关键词
dry emulsion; dissolution; particle; sustained release;
D O I
10.1016/S0378-5173(01)00991-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The behaviour of a pharmaceutical form, called dry adsorbed emulsion (DAE). containing a sparingly soluble drug (i.e. theophylline) was studied for dissolution drug release kinetic, in relation with DAE structure characterisation. In vitro dissolution testings were performed under different experimental conditions (medium at pH 1.2 and 7.4, medium with or without surfactant addition, different particle sizes, discrete or densified particles). Discrete DAE particles showed an extended release, in comparison with the native drug powder, depending on both drug Solubility in the medium and particle size. The relevance of dissolution data was not improved by surfactant addition (0.1% sodium lauryl sulfate: SLS). After an initial release due to theophylline of the DAE superficial layer, the dissolution followed the Higuchi model. This suggested that DAE behaved as an inert matrix, which controlled drug release by diffusion through the hydrophobic part of the DAE. Densified DAE particles showed a slower dissolution rate than discrete DAE particles. because of their weak wettability and their poor disintegrant properties due to the particulate rearrangement under pressure. Lastly in a technological point of view, DAE could be considered as a potential drug delivery system in capsules or tablets to better control bioavailability of drugs. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:169 / 178
页数:10
相关论文
共 24 条
[1]  
[Anonymous], POWDER TECHNOLOGY PH
[2]   DRY ADSORBED EMULSIONS - AN ORAL SUSTAINED DRUG DELIVERY SYSTEM [J].
BERTHOD, A ;
ROLLET, M ;
FARAH, N .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (03) :216-221
[3]  
Brossard C., 1990, STP PHARM, V6, P728
[4]   THE RELATIONSHIP BETWEEN PARTICLE-SIZE AND SOLUBILITY [J].
BUCKTON, G ;
BEEZER, AE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 82 (03) :R7-R10
[5]  
Chambin O, 2000, J PHARM SCI, V89, P991, DOI 10.1002/1520-6017(200008)89:8<991::AID-JPS3>3.0.CO
[6]  
2-#
[7]   Technical optimisation of redispersible dry emulsions [J].
Christensen, KL ;
Pedersen, GP ;
Kristensen, HG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 212 (02) :195-202
[8]   Dissolution media for in vitro testing of water-insoluble drugs: Effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate [J].
Crison, JR ;
Weiner, ND ;
Amidon, GL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (03) :384-388
[9]   Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms [J].
Dressman, JB ;
Amidon, GL ;
Reppas, C ;
Shah, VP .
PHARMACEUTICAL RESEARCH, 1998, 15 (01) :11-22
[10]   DRY EMULSION - A SUSTAINED-RELEASE FORM MODELING OF DRUG TRANSFERS IN LIQUIDS [J].
FARAH, N ;
BOUZON, J ;
ROLLET, M ;
TAVERDET, JL ;
VERGNAUD, JM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 36 (01) :81-88